ANZ News
The Australian government-approved therapy has shown "remarkable" results after 18 sessions.
It has also received Australia's regulatory approval for its AI solution.
Also, New Zealand's The Doctors has cautioned the public about a mobile app posing as its official app.
Developers see a potential use of the AI-powered mobile solution for routine early skin cancer screening.
It has shown 82% accuracy in detecting stroke, comparable to paramedics, according to RMIT University.
Also, digital twin technology is being tested to optimise mechanical ventilation.
A new mobile app encourages adults with ADHD to be more proactive in managing their condition.
Also, Consultmed has released a new genAI feature on its referral management software.
It is now set to take on the international markets three years after its inception.
This is the latest in its string of acquisitions to expand its digital health portfolio.